A federal collective recourse accuses the Faculty of Medicine of the UCLA and various university leaders of using the race as a factor of admission, despite a law of the State and a decision of the Supreme Court writing a positive action.
The trial, filed Thursday before the Federal Court of the California Central District, was brought by the group of activists, did not hurt, founded in 2022 to fight positive action in medicine; Students for fair admissions, the non -profit organization that won its prosecution at the Supreme Court against the Harvard positive action program; And Kelly Mahoney, a university graduate who was rejected from the David Geffen School of Medicine of the UCLA.
According to the trial, legal action has been taken to prevent the Faculty of Medicine and the UCLA officials from “engaging in intentional discrimination on the basis of race and ethnicity in the admission process”.
The UCLA medical school did not immediately respond to a request for comments.
Quoting nameless “denunciators”, the trial alleys that Jennifer Lucero, the associated dean for admissions, “obliges the candidates to submit answers which are intended to allow the committee to glean the applicant’s race, which the Faculty of Medicine subsequently confirms via interviews.”
He also alleys that the members of Lucero and the admissions committee have “systematically and openly” discussed the breed and used it as a factor to make admission decisions.
Lucero did not immediately respond to a request sent by e-mail to comment.
“Do not hurt, it is fighting for all the students who have been racily discriminated against by the UCLA under the guise of political progress,” said Dr Stanley Goldfarb, president of DO No Buds, in a press release. “All medical schools must respect the law of the country and prioritize merit, not the immutable characteristics, in admissions.”
The trial comes as the UCLA and other UC campuses face a meticulous examination of the Trump administration for a potential “illegal dei” in admission practices.
The Ministry of Justice at the end of March said that it would investigate the UCLA, UC Irvine, Stanford and UC Berkeley, suggesting that schools have flouted the State Act and the Previous of the United States Supreme Court prohibiting the use of the race as a factor when assessing college candidates.
An UC spokesman said in a statement on the March investigation that UC had ceased to use the race in admissions when proposal 209 – which prohibits the examination of the race in public education, hiring and contracts – has entered into force in 1997. Since then, “UC has implemented admission practices to comply with the law”.
Separately at the time, the Ministry of Health and Social Services declared that it was investigating an “Named major medical school in California to determine whether it discriminated against the basis of race, color or national origin in its admissions. An HHS official previously told Times that the investigation was focused on the UCLA David Geffen School of Medicine.
In response to this announcement in March, the UCLA said: “We will cooperate fully with their investigation”.
The trial Thursday alleges that Lucero and the admissions committee regularly admit black candidates with admission test scores below the average and the MCAT, or admission scores to the medical college, “while forcing whites and Asians to have scores almost perfect to be seriously considered.”
According to the trial, not to harm at least one member who applied to Geffen, has been rejected and “is capable and ready to reapplicate if a court orders the defendants to stop discriminating and to undo the effects of his past discrimination.” Students for fair admissions have at least one member who will apply for the Faculty of Medicine.
“In this system based on race,” says the trial, “all candidates are deprived of their right to equal treatment and the possibility of continuing their dream for life to become a doctor because of completely arbitrary criteria.”
California Daily Newspapers
